Heritage Global Partners, in conjunction with Surplus Solutions, is selling late model biotechnology laboratory equipment surplus to the ongoing operations of Celularity.
Clinical and commercial stage biotechnology company Celularity develops off-the-shelf allogeneic cell therapies derived from placenta and used in the treatment of cancer, infectious, immunologic and degenerative diseases.
The online auction opens on the 21st of August and ends on the 23rd of August. Lots featured in the sale include: Cytivia AKTA Avant 150 chromatography system, (2) Sartorius Stedim BIOSTAT STR 50L cell cultivation system, (6) Fresenius Kabi LOVO cell processing system, Cytek Aurora flow cytometer, (2) Miltenyi CliniMACS Plus cell separation system, Li-Cor Odyssey CLx imaging system, (2) Acea xCELLigence single-plate real time cell analyzer, (20+) Cytivia/GE Xuri cell expansion system W25, (2) Beckman Coulter Vi-Cell XR cell viability analyzer, Thermo Fisher Nanodrop 2000, Beckman Coulter Multisizer 4e Coulter cell analyzer, (15) Terumo sterile tubing welder, Zeiss Axiovert 40CFL microscope, Applied Biosciences QuantStudio Absolute Q, Tuttnauer electronic laboratory autoclave and more. The assets are located in Florham Park, New Jersey and can be viewed by appointment with the auctioneer only.
Headquartered in San Diego, California Heritage Global Partners is a full-service auctioneering company managing sales at all scales – from single assets through to complete turn-key facilities and factories. Heritage Global Partners works with clients across 28 different manufacturing, financial and technology industries, including the electronics, pharmaceutical, energy and food and beverage sectors.
For further information about this, or any other Heritage Global Partners auction, please visit:
